<html>
<head>PUBMED IDs for MMRN</head>
<body bgcolor='#C5F0F2'><h1>MMRN</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10828608/'>The human multimerin gene MMRN maps to chromosome 4q22.</a> June 1  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/15815727/'>Identification of genes potentially involved in disease transformation of CML.</a> April 9  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/21058943/'>Replication of GWAS associations for GAK and MAPT in Parkinson's disease.</a> April 6  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22020326/'>MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway.</a> September 6  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22685416/'>Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.</a> September 27  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23979707/'>SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers.</a> August 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25294124/'>An exome study of Parkinson's disease in Sardinia, a Mediterranean genetic isolate.</a> August 28  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25745997/'>Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth.</a> March 5  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25825478/'>Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.</a> May 11  2015<br></body></html>
